G. Ritchie

607 total citations
14 papers, 430 citations indexed

About

G. Ritchie is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G. Ritchie has authored 14 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in G. Ritchie's work include Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Hormonal and reproductive studies (2 papers). G. Ritchie is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Hormonal and reproductive studies (2 papers). G. Ritchie collaborates with scholars based in Australia, United Kingdom and Qatar. G. Ritchie's co-authors include Sarah J. Lord, Chee Khoon Lee, Johnathan Man, Ian C. Marschner, Michael Friedländer, Mark Rodgers, Tev Aho, Jos Kleijnen, Marie Westwood and Steven Duffy and has published in prestigious journals such as Diabetes Care, Cochrane Database of Systematic Reviews and BMJ.

In The Last Decade

G. Ritchie

14 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Ritchie Australia	11	139	105	83	51	46	14	430
Siddharth Karanth United States	10	177 1.3×	92 0.9×	45 0.5×	89 1.7×	18 0.4×	29	375
Vivek Srivastava India	11	153 1.1×	80 0.8×	249 3.0×	49 1.0×	23 0.5×	69	574
Charlotte Burmeister United States	14	86 0.6×	69 0.7×	110 1.3×	79 1.5×	19 0.4×	46	456
Louise Crathorne United Kingdom	14	160 1.2×	90 0.9×	94 1.1×	35 0.7×	24 0.5×	33	559
Rosanna Wustrack United States	12	135 1.0×	132 1.3×	273 3.3×	75 1.5×	21 0.5×	38	542
Gareth Lloyd United Kingdom	9	289 2.1×	60 0.6×	175 2.1×	69 1.4×	40 0.9×	23	506
Christopher T. Chen United States	11	51 0.4×	63 0.6×	120 1.4×	68 1.3×	36 0.8×	30	507
Carlo Lazzaro Italy	14	72 0.5×	273 2.6×	67 0.8×	72 1.4×	28 0.6×	47	742
Meera M. Dhodapkar United States	9	88 0.6×	37 0.4×	131 1.6×	31 0.6×	27 0.6×	57	393
Martin J. O’Sullivan Ireland	16	180 1.3×	111 1.1×	233 2.8×	62 1.2×	33 0.7×	42	643

Countries citing papers authored by G. Ritchie

Since Specialization

Citations

This map shows the geographic impact of G. Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Ritchie more than expected).

Fields of papers citing papers by G. Ritchie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Ritchie. The network helps show where G. Ritchie may publish in the future.

Co-authorship network of co-authors of G. Ritchie

This figure shows the co-authorship network connecting the top 25 collaborators of G. Ritchie. A scholar is included among the top collaborators of G. Ritchie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Ritchie. G. Ritchie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kok, Peey‐Sei, G. Ritchie, Ian C. Marschner, et al.. (2020). Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials. JAMA Network Open. 3(9). e2011809–e2011809. 33 indexed citations

Ritchie, G., Johnathan Man, Sarah J. Lord, et al.. (2018). Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers. JAMA Oncology. 4(4). 522–522. 80 indexed citations

Man, Johnathan, G. Ritchie, Matthew Links, Sarah J. Lord, & Chee Khoon Lee. (2018). Treatment‐related toxicities of immune checkpoint inhibitors in advanced cancers: A meta‐analysis. Asia-Pacific Journal of Clinical Oncology. 14(3). 141–152. 35 indexed citations

Ritchie, G., et al.. (2017). Is objective response rate (ORR) a valid primary endpoint in phase 2 trials (Ph2t) of immune checkpoint inhibitors (ICI) for advanced solid cancers?. Annals of Oncology. 28. v411–v411. 4 indexed citations

Ritchie, G., Mangalee Fernando, & David Goldstein. (2016). Rituximab to treat gemcitabine-induced hemolytic–uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review. Cancer Chemotherapy and Pharmacology. 79(1). 1–7. 13 indexed citations

Dworzynski, Katharina, et al.. (2013). Rehabilitation after stroke: summary of NICE guidance. BMJ. 346(jun12 1). f3615–f3615. 49 indexed citations

Ritchie, G., André Pascal Kengne, Rohina Joshi, et al.. (2010). Comparison of Near-Patient Capillary Glucose Measurement and a Risk Assessment Questionnaire in Screening for Type 2 Diabetes in a High-Risk Population in Rural India. Diabetes Care. 34(1). 44–49. 21 indexed citations

Norman, Gill, Ruth E. Langley, Z. Hodges, et al.. (2008). Parenteral oestrogen in the treatment of prostate cancer: a systematic review. British Journal of Cancer. 98(4). 697–707. 23 indexed citations

Rodgers, Mark, Susanne Hempel, Tev Aho, et al.. (2006). Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation. Health Technology Assessment. 10(18). iii–iv, xi. 103 indexed citations

10.

Fayter, Debra, Catriona McDaid, G. Ritchie, Lisa Stirk, & Alison Eastwood. (2006). Systematic review of barriers, modifiers and benefits involved in participation in cancer clinical trials. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 29 indexed citations

11.

Norman, Gill, Z. Hodges, G. Ritchie, et al.. (2006). Parenteral oestrogens for prostate cancer: a systematic review of clinical effectiveness and dose response. 1 indexed citations

12.

McDaid, Catriona, et al.. (2005). Systematic review of effectiveness of different treatments for childhood retinoblastoma. Health Technology Assessment. 9(48). iii, ix–x, 1. 13 indexed citations

13.

Rodgers, Mark, et al.. (2005). The effects of psychosocial interventions in cancer and heart disease: a review of systematic reviews. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 8 indexed citations

14.

Forbes, Angus, et al.. (2004). Effectiveness of intermediate care in nursing-led in-patient units. Cochrane Database of Systematic Reviews. CD002214–CD002214. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact